RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest

Nutrition and Cancer
W YuK Kline

Abstract

RRR-alpha-tocopheryl succinate (vitamin E succinate, VES) treatment of murine EL4 T lymphoma cells induced the cells to undergo apoptosis. After 48 hours of VES treatment at 20 micrograms/ml, 95% of cells were apoptotic. Evidence for the induction of apoptosis by VES treatments is based on staining of DNA for detection of chromatin condensation/fragmentation, two-color flow-cytometric analyses of DNA content, and end-labeled DNA and electrophoretic analyses for detection of DNA ladder formation. VES-treated EL4 cells were blocked in the G1 cell cycle phase; however, apoptotic cells came from all cell cycle phases. Analyses of mRNA expression of genes involved in apoptosis revealed decreased c-myc and increased bcl-2, c-fos, and c-jun mRNAs within three to six hours after treatment. Western analyses showed increased c-Jun, c-Fos, and Bcl-2 protein levels. Electrophoretic mobility shift assays showed increased AP-1 binding at 6, 12, and 24 hours after treatment and decreased c-Myc binding after 12 and 24 hours of VES treatment. Treatments of EL4 cells with VES+RRR-alpha-to-copherol reduced apoptosis without effecting DNA synthesis arrest. Treatments of EL4 cells with VES+rac-6-hydroxyl-2, 5,7,8-tetramethyl-chroman-2-carboxylic ac...Continue Reading

References

Oct 1, 1992·Journal of the American College of Nutrition·K N Prasad, J Edwards-Prasad
Jan 1, 1992·Annual Review of Biochemistry·K B MarcuA J Patel
Jun 1, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S B McMahon, J G Monroe
Aug 18, 1988·Nature·W W LamphI M Verma
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S Munro, T Maniatis
Jan 1, 1989·Nutrition and Cancer·R Slack, P Proulx
Nov 1, 1983·Proceedings of the Society for Experimental Biology and Medicine·B N Rama, K N Prasad
Oct 22, 1993·Cell·D M HockenberyS J Korsmeyer

❮ Previous
Next ❯

Citations

Jul 26, 2005·Cancer Immunology, Immunotherapy : CII·Lalitha V RamanathapuramEmmanuel T Akporiaye
Jan 9, 2004·The Journal of Nutritional Biochemistry·Michael BergmanHanna Bessler
Aug 30, 2000·Proceedings of the Society for Experimental Biology and Medicine·B S McIntyreP W Sylvester
Jan 29, 2002·Surgery·Mokenge P MalafaMichele King
Apr 17, 2008·Molecular Cancer Therapeutics·Minsub Shim, Thomas E Eling
Feb 28, 2013·Reproductive Biology and Endocrinology : RB&E·Jonathan M GreenePeter L Ryan
Jan 10, 2012·Biological & Pharmaceutical Bulletin·Mai IshibashiToshihiko Hirano
Dec 30, 2009·Journal of Pharmaceutical Sciences·Stepán KoudelkaJaroslav Turánek
Dec 17, 2008·Molecular Nutrition & Food Research·Yan ZhaoKun Wu
Jul 14, 2007·Vitamins and Hormones·Marco Tomasetti, Jiri Neuzil
Jul 12, 2017·Journal of Biomaterials Science. Polymer Edition·Ebru KilicayEmir Baki Denkbas
Jul 28, 2015·Cancers·Irene RussoMauro Alaibac
Mar 14, 2000·Journal of Dairy Science·M ColittiB Stefanon
Dec 29, 2005·International Journal of Cancer. Journal International Du Cancer·Mokenge P MalafaKounosuke Watabe
Jul 12, 2012·Anatomia, histologia, embryologia·M Colitti
Apr 4, 2003·Journal of the American College of Nutrition·Kedar N PrasadWilliam C Cole
Mar 1, 2006·Molecular Cancer Therapeutics·Sreenivasa DonapatyMokenge P Malafa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.